Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway developers explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers. Based on insights from 15 U.S. payers and providers, it reveals:

• The critical role of OCPs in treatment decisions and cost management
• Opportunities for manufacturers to share pre-approval information
• Key evidence needs for pathway inclusion
• Optimal communication strategies with OCP stakeholders
• Future trends in pathway comprehensiveness

Essential reading for oncology market access professionals looking to stay ahead in an evolving landscape and gain actionable insights on communicating your oncology product’s value and optimizing its pathway positioning.

Please complete the form to download the paper >